Rexahn Pharmaceuticals, Inc. (REXN) related to its combination with Ocuphire Pharma, Inc. Under the terms of the agreement, Rexahn will issue 4.6979 shares of Rexahn common stock to Ocuphire shareholders for each share of Ocuphire common stock owned.